Stay updated on CP-690,550 Dose Comparison in RA Clinical Trial

Sign up to get notified when there's something new on the CP-690,550 Dose Comparison in RA Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CP-690,550 Dose Comparison in RA Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page has removed a citation regarding the efficacy and safety of tofacitinib, including an erratum reference.
    Difference
    0.1%
    Check dated 2025-05-08T05:42:32.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-05-01T03:27:51.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed information about a Phase 3 study on CP 690,550 for Rheumatoid Arthritis, while a new version number has been added.
    Difference
    5%
    Check dated 2025-04-16T14:22:47.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-09T09:05:12.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-04-01T23:10:32.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.5%
    Check dated 2025-02-24T20:57:25.000Z thumbnail image

Stay in the know with updates to CP-690,550 Dose Comparison in RA Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CP-690,550 Dose Comparison in RA Clinical Trial page.